Your browser doesn't support javascript.
loading
Mutations in DEAD/H-box helicase 11 correlate with increased relapse risk in adults with acute myeloid leukaemia with normal cytogenetics.
Zhou, Ya-Lan; Zhao, Ming-Yue; Gale, Robert Peter; Jiang, Hao; Jiang, Qian; Liu, Li-Xia; Qin, Jia-Yue; Cao, Shan-Bo; Lou, Feng; Xu, Lan-Ping; Zhang, Xiao-Hui; Huang, Xiao-Jun; Ruan, Guo-Rui.
Afiliación
  • Zhou YL; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.
  • Zhao MY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.
  • Gale RP; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, UK.
  • Jiang H; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.
  • Jiang Q; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.
  • Liu LX; Acornmed Biotechnology Co., Ltd., Tianjin, China.
  • Qin JY; Acornmed Biotechnology Co., Ltd., Tianjin, China.
  • Cao SB; Acornmed Biotechnology Co., Ltd., Tianjin, China.
  • Lou F; Acornmed Biotechnology Co., Ltd., Tianjin, China.
  • Xu LP; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.
  • Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.
  • Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China. huangxiaojun@bjmu.edu.cn.
  • Ruan GR; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China. huangxiaojun@bjmu.edu.cn.
Leukemia ; 38(1): 223-225, 2024 01.
Article en En | MEDLINE | ID: mdl-37993668
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Recurrencia Local de Neoplasia Límite: Adult / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Recurrencia Local de Neoplasia Límite: Adult / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido